Skip to main content

Table 3 Secondary outcomes

From: Angiotensin II receptor 1 antibodies associate with post-transplant focal segmental glomerulosclerosis and proteinuria

 

FSGS n = 49

No FSGS n = 51

OR (95% CI)

p-value

Renal allograft loss

31/49 (63%)

20/51 (39%)

2.6694 (1.1895 to 5.9905)

0.0173

Death-censored allograft loss

29/49 (59%)

13/51 (25.5%)

4.2385 (1.8130 to 9.9086)

0.0009

All-cause mortality

8/49 (16.3%)

13/51 (25.4%)

0.5704 (0.2130 to 1.5275)

0.2639

Mean graft survival time 95% Confidence Interval

52.48 months (38.94–66.02)

54.20 months (37.51–70.88)

Not applicable

0.8702

  1. FSGS group showed higher renal allograft loss than the comparison group with statistically significant odds ratio as shown. This was more evident in the death-censored renal allograft loss with higher odds ratio and statistical significance. All-cause mortality was lower in FSGS group than the comparison group; however the difference was not statistically significant. Mean allograft survival was almost similar in both groups without statistically significant differences
  2. Data are presented as percentage (%) unless otherwise mentioned
Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us